Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

1993745 citationsJournal Articlebronze Open Access

Authors

Jessie R. Groothuis · University of Colorado Denver

Eric A. F. Simões

Myron J. Levin · University of Colorado Denver

Caroline Breese Hall

Christine Long

William J. Rodríguez · Children's National

Julita O. Arrobio · Children's National

H. Cody Meissner · Tufts University

Abstract

Administration of high doses of respiratory syncytial virus immune globulin is a safe and effective means of preventing lower respiratory tract infection in infants and young children at high risk for this disease.

Topics & Keywords

Respiratory viral infections research Kawasaki Disease and Coronary Complications Congenital Diaphragmatic Hernia Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 329, Issue 21, pp. 1524-1530

DOI: 10.1056/nejm199311183292102

Field-Weighted Citation Impact: 23.24